Product

Recombinant von Willebrand Factor

2 clinical trials

2 indications

Indication

Von Willebrand Disease

Indication

Bleeding Disorder

Clinical trial

A Phase 3, Prospective, Open-label, Uncontrolled, Multicenter Study on Efficacy and Safety of Prophylaxis With rVWF in Children Diagnosed With Severe Von Willebrand Disease

Status: Not yet recruiting, Estimated PCD: 2027-02-20

Clinical trial

Safety and Tolerability of Recombinant Von Willebrand Factor Concentrate in Adult ECMO Patients With Major Bleeding: A Phase I Study

Status: Not yet recruiting, Estimated PCD: 2026-08-31